多组学揭示了ELAVL3通过免疫细胞死亡调节神经母细胞瘤中的MYCN:风险分层和实验研究

Peng Hong1, Zaihong Hu1, Jie Lin1

  • 1Department of Urology, Children's Hospital of Chongqing Medical University; National Clinical Research Center for Child Health and Disorders; Ministry of Education Key Laboratory of Child Development and Disorders; Chongqing Key Laboratory of Structural Birth Defect and Reconstruction, China.

概括

一个新的免疫细胞死亡相关指数 (ICDR-Index) 准确预测神经母细胞瘤 (NB) 风险,识别出存活率差且免疫治疗反应低的患者. 准ELAVL3显示了减少NB恶性瘤和增强抗瘤免疫力的潜力.